⌘K

Login Start Free

Home/Filings/4/0001209191-22-038864

4//SEC Filing

Dubin Glenn 4

Accession 0001209191-22-038864

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:16 PM ET

Size

5.4 KB

Accession

0001209191-22-038864

Insider Transaction Report

Form 4

Period: 2022-06-22

C4 Therapeutics, Inc.CCCC

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-22+23,500→ 23,500 total
Exercise: $6.06Exp: 2032-06-21→ Common Stock (23,500 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001308597

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 4:16 PM ET
Size: 5.4 KB

View on SEC.gov